25.11.2014 Views

Guidance on data sharing - ECHA - Europa

Guidance on data sharing - ECHA - Europa

Guidance on data sharing - ECHA - Europa

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<str<strong>on</strong>g>Guidance</str<strong>on</strong>g> <strong>on</strong> <strong>data</strong> <strong>sharing</strong><br />

Versi<strong>on</strong> 2.0 April 2012<br />

35<br />

• Downstream users who may be in possessi<strong>on</strong> of <strong>data</strong>, and thus have a lot to c<strong>on</strong>tribute in the collecti<strong>on</strong><br />

of <strong>data</strong> to be used for registrati<strong>on</strong>, possibly in relati<strong>on</strong> to intrinsic properties, but in particular in relati<strong>on</strong> to<br />

quantificati<strong>on</strong> of exposure and estimati<strong>on</strong> of risks. Hence, downstream users need to be involved as early as<br />

possible in the <strong>data</strong> <strong>sharing</strong> process. In accordance with the provisi<strong>on</strong>s of Article 28(7) of the REACH Regulati<strong>on</strong>,<br />

downstream users may submit informati<strong>on</strong> <strong>on</strong> pre-registered substances as well as any other relevant<br />

informati<strong>on</strong> for those substances, with the intenti<strong>on</strong> of becoming a member (<strong>data</strong> holder) of the corresp<strong>on</strong>ding<br />

SIEF.<br />

Informati<strong>on</strong> from downstream users may help potential registrants to waive certain tests based <strong>on</strong> lack of<br />

exposure (absence of risks for instance, or irrelevance of test type due to no exposure). Indeed, exposurebased<br />

waiving is fundamental to reducing the need for animal testing.<br />

NB: Downstream users are advised to establish c<strong>on</strong>tact with their suppliers and to obtain informati<strong>on</strong><br />

as so<strong>on</strong> as possible regarding the formati<strong>on</strong> of a corresp<strong>on</strong>ding SIEF, rather than wait for potential<br />

registrants to c<strong>on</strong>tact them. Specifically, when downstream users have valuable <strong>data</strong> regarding safety,<br />

including hazard <strong>data</strong>, uses, exposure and risks, it is recommended that they communicate as early as<br />

possible with their suppliers in order to ensure to best possible use of their <strong>data</strong>.<br />

• Other third parties holding informati<strong>on</strong> <strong>on</strong> phase-in substances, such as:<br />

oo<br />

Trade or industry associati<strong>on</strong>s, sector specific groups and c<strong>on</strong>sortia already formed.<br />

oo<br />

N<strong>on</strong> Governmental Organisati<strong>on</strong>s (NGOs), research laboratories, universities, internati<strong>on</strong>al or<br />

nati<strong>on</strong>al agencies.<br />

oo<br />

Manufacturers of a substance who have no interest in registering a substance under REACH because<br />

they do not produce or place it <strong>on</strong> the market in Europe (e.g. a n<strong>on</strong>-EU manufacturer who does not export<br />

into the EU).<br />

When indicating in the REACH-IT system the pre-registered substances <strong>on</strong> which they hold informati<strong>on</strong>, the<br />

<strong>data</strong> holders will have the possibility to indicate other types of informati<strong>on</strong>, in particular with regards to<br />

safety, such as hazard <strong>data</strong> and informati<strong>on</strong> <strong>on</strong> uses. They can usefully indicate their intenti<strong>on</strong> to share <strong>data</strong><br />

for read-across where relevant. On the pre-SIEF page (in REACH-IT) the <strong>data</strong> holder will not see the identities<br />

of the pre-SIEF members, but his informati<strong>on</strong> (c<strong>on</strong>tact details and <strong>data</strong> available) are visible for the<br />

pre-SIEF member(s), who then need to decide whether to c<strong>on</strong>tact the <strong>data</strong> holder.<br />

It must be underlined that REACH does not provide for <strong>data</strong> holders to have an active role in deciding <strong>on</strong><br />

the studies to be included in the joint submissi<strong>on</strong> and <strong>on</strong> classificati<strong>on</strong> and labelling proposals. Data holders<br />

will not be involved in pre-SIEF discussi<strong>on</strong>s. They will be c<strong>on</strong>sidered as members of the relevant SIEF <strong>on</strong>ce<br />

formed.<br />

Potential registrants may <strong>on</strong>ly start investigating <strong>data</strong> availability <strong>on</strong>ce the SIEF is formed and when they<br />

have identified <strong>data</strong> gaps (see secti<strong>on</strong> 3.3 below). In any case potential registrants are likely to first review<br />

the <strong>data</strong> they have in their possessi<strong>on</strong> before c<strong>on</strong>tacting any <strong>data</strong> holder mainly to fill <strong>data</strong> gaps. At this<br />

stage, they can launch requests for missing <strong>data</strong> (this is mandatory if the missing <strong>data</strong> involve vertebrate<br />

animal testing). Potential registrants must bear in mind that there may be several SIEFs corresp<strong>on</strong>ding to<br />

the entry in the list of pre-registered substances. Requests must c<strong>on</strong>sequently be sent to all <strong>data</strong> holders<br />

corresp<strong>on</strong>ding to the entry in the list of pre-registered substances, and possibly those in another entry if the<br />

final SIEF is the result of a merger of several pre-registered substances.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!